期刊文献+

阿卡波糖联合西格列汀治疗Ⅱ型糖尿病的效果探究

下载PDF
导出
摘要 目的 :研究用阿卡波糖联合西格列汀治疗Ⅱ型糖尿病的效果。方法 :选取2016年2月至2017年9月重庆市垫江县中医院接诊的76例Ⅱ型糖尿病患者作为研究对象。根据治疗方法的不同将其分为观察组和对照组(38例/组)。为对照组患者单用阿卡波糖进行治疗,为观察组患者联用阿卡波糖和西格列汀进行治疗。然后比较两组患者空腹血糖(FPG)、餐后2小时血糖(2h PG)的水平、SCL-90评分及不良反应的发生情况。结果:治疗后,观察组患者FPG、2hPG的水平、SCL-90评分均低于对照组患者,P<0.05。在用药期间,观察组患者不良反应的发生率[7.89%(3/38)]与对照组患者不良反应的发生率[5.26%(2/38)]相比,P>0.05。结论:用阿卡波糖联合西格列汀治疗Ⅱ型糖尿病能够有效地改善患者血糖的水平,提高其生活质量,且安全性较高。
作者 程萍
出处 《当代医药论丛》 2018年第15期133-134,共2页
  • 相关文献

参考文献5

二级参考文献62

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8233
  • 2Ahren B, Paeini G, Foley JE, et al. Improved meal-nelated [?-cell function and insullin sensitivity by the dipeptidyl petidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 years. Diabetes Care,2005,28:1936-1940.
  • 3Iwasaki M, Hoshian F, Tsuji T, et al. Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabe- tes:Association of glycated hemoglobin reduction with serum eicosapentaenoie acid and docosahexaenoic acid levels. J Diabe- tes Investig, 2012,3 : 464-467.
  • 4Aoki K, Masuda K, Miyazaki T, et al. Effects of miglitol, sita- gliptin or their combination on plasma glucose, insulin and in- cretin levels in non-diabetic men. Endocr ], 2010,57 : 667-672.
  • 5AGREE COLLABORATION. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines:the AGREE project, Qual. Saf[J]. Health Care,2003,12(1):18-23.
  • 6AMERICAN DIABETES ASSOCIATION. Standards of medical care in diabetes 2015[J]. Diabetes Care,2015,38(suppl):4.
  • 7HANDELSMAN Y, BLOOMGARDEN Z T, GRUNBERGER G, et al. American association of clinical endocrinologists and american college of endocrinology-clinical practice guidelines for developing a diabetes mellitus comprehensive care plan-2015[J]. Endocr Pract, 2015,21(suppl 1):187.
  • 8NATIONAL INSTITUTE FOR HEALTH AND CARE EXCEL-LENCE. Type 2 diabetes:The management of type 2 diabetes[EB/OL]. London (UK):National Institute for Health and Clinical Excellence,2009(Updated in 2014),[2015-11-02]. https://www.nice.org.uk/guidance/cg87.
  • 9INTERNATIONAL DIABETES FEDERATION GUIDELINE DEVELOPMENT GROUP.Global guideline for type 2 diabetes[J]. Diabetes Res Clin Pract, 2014,104(1):152.
  • 10INTERNATIONAL DIABETES FEDERATION GUIDELINE DEVELOPMENT GROUP. Guideline for management of postmeal glucose in diabetes[J]. Diabetes Res Clin Pract, 2014, 103(2):256-268.

共引文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部